|

Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest

RECRUITINGSponsored by Children's Hospital of Philadelphia
Actively Recruiting
SponsorChildren's Hospital of Philadelphia
Started2024-07-01
Est. completion2029-06-30
Eligibility
Age37 Weeks – 18 Years
Healthy vol.Accepted
Locations22 sites

Summary

This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of this study is to evaluate the physiologic response to epinephrine as an outcome discriminator in pediatric in-hospital cardiac arrest (IHCA). In addition, the investigators will determine optimal epinephrine dosing strategies based on the initial physiologic response to epinephrine, and to develop machine learning (ML) algorithms to guide intra-arrest therapy.

Eligibility

Age: 37 Weeks – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Arrest in an ICU
* Patients received chest compressions for at least 1 minute

Exclusion Criteria:

* Lack of commitment to aggressive therapies (e.g., CPR performed as part of end-of-life care)
* Brain death determination prior to CPR
* Out-of-hospital cardiac arrest was the reason for initial admission to the hospital (known poor outcomes)
* Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation at the start of CPR

Conditions2

Cardiac Arrest (CA)Heart Disease

Locations22 sites

CHOC
Orange, California, 92868
Jennifer Hayes909-614-3592jhayes@choc.org
Stanford Medicine Children's Health
Stanford, California, 94305
Felice Su650-736-7632felicesu@stanford.edu
Children's Hospital Colorado
Nemours Children's Health
Wilmington, Delaware, 19803
Yosef Levenbrown201-390-4961Yosef.Levenbrown@nemours.org
Children's Healthcare of Atlanta
Stephanie Brown216-333-3806stephanie.rachelle.brown@emory.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.